Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kaehler, Katharina C.; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pfoehler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

Author:

Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kaehler, Katharina C.; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pfoehler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael

Tübinger Autor(en):

Eigentler, Thomas
Leiter-Stöppke, Ulrike

Published in:

Cancers (2022), Bd. 14 (7), Article 1804

Verlagsangabe:

Mdpi

Language:

English

Full text:

http://dx.doi.org/10.3390/cancers14071804

ISSN:

2072-6694